Accendra Health (ACH) Cost of Revenue (2009 - 2026)

Accendra Health (ACH) has 18 years of Cost of Revenue data on file, last reported at $315.4 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $315.4 million, down 0.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 55.44% YoY), and the FY2025 annual result was $1.3 billion, up 6.23% from the prior year.
• Cost of Revenue declined to $315.4 million in Q1 2026 per ACH's latest filing, from $348.8 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $2.1 billion in Q4 2022 and troughed at -$4.9 billion in Q4 2023.
• A 5-year average of $797.1 million and a median of $348.8 million in 2025 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2025: Cost of Revenue slumped 330.87% in 2023, then surged 4304.09% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $2.1 billion in 2022, then sank by 330.87% to -$4.9 billion in 2023, then soared by 104.2% to $208.0 million in 2024, then soared by 67.7% to $348.8 million in 2025, then retreated by 9.57% to $315.4 million in 2026.
• Business Quant data shows ACH's Cost of Revenue at $315.4 million in Q1 2026, $348.8 million in Q4 2025, and $337.6 million in Q3 2025.